Literature DB >> 5396493

In vitro and in vivo evaluation of cefazolin, a new cephalosporin C derivative.

M Nishida, T Matsubara, T Murakawa, Y Mine, Y Yokota, S Kuwahara, S Goto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5396493

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother (Bethesda)


× No keyword cloud information.
  22 in total

1.  Dosage adjustments of cefazolin according to the pharmacokinetics of this new cephalosporin.

Authors:  J Lavillaureix; J M Brogard; M Pinget; F Ledoux
Journal:  Infection       Date:  1975       Impact factor: 3.553

Review 2.  Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications.

Authors:  W A Craig; P G Welling
Journal:  Clin Pharmacokinet       Date:  1977 Jul-Aug       Impact factor: 6.447

3.  Antibacterial activity and pharmacokinetic behavior of cefazolin as compared with five other cephalosporin antibiotics.

Authors:  P Naumann; E Reintjens
Journal:  Infection       Date:  1974       Impact factor: 3.553

Review 4.  Newer beta-lactam antibiotics.

Authors:  J M Hamilton-Miller; W Brumfitt
Journal:  Infection       Date:  1974       Impact factor: 3.553

5.  Rate of binding of antibiotics to canine serum protein.

Authors:  N Waterman; L Scharfenberger; M J Raff
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

6.  Binding of cefalotin to human serum albumin.

Authors:  M O Decroix; J C Chaumeil; B Flouvat
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jul-Sep       Impact factor: 2.441

7.  Semiautomated turbidimetric microbiological assay for determination of cefazolin.

Authors:  D Pitkin; P Actor; W Holl; A Post; J A Weisbach
Journal:  Antimicrob Agents Chemother       Date:  1974-03       Impact factor: 5.191

8.  Pharmacodynamics of cefazolin in the presence of normal and impaired renal function.

Authors:  M F Rein; F B Westervelt; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1973-09       Impact factor: 5.191

9.  [An investigation into the influence of human serum on the in-vitro activity of various cephalosporins (author's transl)].

Authors:  R Ratschow; J R Krone
Journal:  Infection       Date:  1977       Impact factor: 3.553

10.  In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.

Authors:  N Watanabe; K Katsu; M Moriyama; K Kitoh
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.